Razupenem

DB12587InvestigationalSmall molecule

Razupenem has been used in trials studying the treatment of Skin Infections.

Mechanism: Pharmacologically active on Penicillin-binding protein
Curator reviewed
Formula / weight: C₁₈H₂₁N₃O₄S₂ · 407.5 g/mol (avg)
Code names: PZ-601 · SM-216601 · SMP-601

Resolves to

Compound

Structure

InChIKeyXFGOMLIRJYURLQ-GOKYHWASSA-NSMILESC[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(SC3=NC(=CS3)C3=C[C@H](C)NC3)=C(N2C1=O)C(O)=O

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Razupenem, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.